| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0007114509992017 |
| P8608 | Fatcat ID | release_3wrkcbvrg5akdlrihsjl2q6adm |
| P698 | PubMed publication ID | 19781131 |
| P50 | author | Jane Coad | Q98773896 |
| Welma Stonehouse | Q86591688 | ||
| Pamela von Hurst | Q87876917 | ||
| P2860 | cites work | Ethnic Differences in C-Reactive Protein Concentrations | Q57413962 |
| Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man | Q68872505 | ||
| Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo | Q70142172 | ||
| Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells | Q73183118 | ||
| Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level | Q73396246 | ||
| The urgent need to recommend an intake of vitamin D that is effective | Q79896818 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Use and abuse of HOMA modeling | Q28263292 | ||
| Correct homeostasis model assessment (HOMA) evaluation uses the computer program | Q28290512 | ||
| Adipose tissue as an endocrine organ | Q29620407 | ||
| Study protocol--metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention | Q33356265 | ||
| Determinants of vitamin D status in older women living in a subtropical climate | Q33844780 | ||
| Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes | Q33929585 | ||
| Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol | Q34166759 | ||
| Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction | Q34316970 | ||
| The insulin resistance syndrome: definition and dietary approaches to treatment | Q34433299 | ||
| Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial | Q34511555 | ||
| The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis | Q36158245 | ||
| Vitamin D replacement in Asians with diabetes may increase insulin resistance | Q36613084 | ||
| Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. | Q36679184 | ||
| Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000 | Q36906320 | ||
| Identification of a Vitamin D response element in the human insulin receptor gene promoter | Q40652874 | ||
| Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). | Q40717321 | ||
| Current understanding of the molecular actions of vitamin D. | Q40838113 | ||
| Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. | Q42685427 | ||
| Glucose tolerance and vitamin D: effects of treating vitamin D deficiency | Q43551847 | ||
| High prevalence of hypovitaminosis D in female type 2 diabetic population | Q43687931 | ||
| 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes | Q43715735 | ||
| Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? | Q44231254 | ||
| 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level | Q44283041 | ||
| Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction | Q44527038 | ||
| A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. | Q46173867 | ||
| Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season | Q46282196 | ||
| Acute effect of exercise on plasma leptin level and insulin resistance in obese women with stable caloric intake | Q46756608 | ||
| Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. | Q49040755 | ||
| Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. | Q51555713 | ||
| Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. | Q51568341 | ||
| Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. | Q51911247 | ||
| Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes | Q57303280 | ||
| Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus | Q57385138 | ||
| P433 | issue | 4 | |
| P921 | main subject | New Zealand | Q664 |
| vitamin | Q34956 | ||
| vitamin D | Q175621 | ||
| placebo | Q269829 | ||
| insulin resistance | Q1053470 | ||
| vitamin D deficiency | Q4138762 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 549-555 | |
| P577 | publication date | 2009-09-28 | |
| P1433 | published in | British Journal of Nutrition | Q4970206 |
| P1476 | title | Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial | |
| P478 | volume | 103 |
| Q55026978 | 1,25-Dihydroxyvitamin D increases the gene expression of enzymes protecting from glucolipotoxicity in peripheral blood mononuclear cells and human primary endothelial cells. |
| Q35013170 | 25-Hydroxyvitamin D Supplementation and BMI Change: A Meta-Analysis of Randomized Controlled Trials |
| Q53353211 | 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). |
| Q36882152 | 25-Hydroxyvitamin D(3)-loaded PLA microspheres: in vitro characterization and application in diabetic periodontitis models |
| Q38045398 | A four-stage model explaining the higher risk of Type 2 diabetes mellitus in South Asians compared with European populations |
| Q36832945 | A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum |
| Q46439896 | A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans |
| Q92372507 | A systematic review and meta-analysis of the response of serum 25-hydroxyvitamin D concentration to vitamin D supplementation from RCTs from around the globe |
| Q64987406 | Analysis of Association between Vitamin D Deficiency and Insulin Resistance. |
| Q92633457 | Analytical Bias in the Measurement of Plasma 25-Hydroxyvitamin D Concentrations in Infants |
| Q34223502 | Anti-diabetic effect of a preparation of vitamins, minerals and trace elements in diabetic rats: a gender difference. |
| Q39563019 | Association of 25-hydroxyvitamin D with type 2 diabetes among patients undergoing coronary angiography: cross-sectional findings from the LUdwigshafen Risk and Cardiovascular Health (LURIC) Study |
| Q53689858 | Association of Insulin Resistance with Bone Strength and Bone Turnover in Menopausal Chinese-Singaporean Women without Diabetes. |
| Q36830511 | Association of racial disparities in the prevalence of insulin resistance with racial disparities in vitamin D levels: National Health and Nutrition Examination Survey (2001-2006) |
| Q51361346 | Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland. |
| Q61807249 | Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis |
| Q87562522 | Bioavailability of vitamin D2 from enriched mushrooms in prediabetic adults: a randomized controlled trial |
| Q49588339 | Calcitriol concomitantly enhances insulin sensitivity and alters myocellular lipid partitioning in high fat-treated skeletal muscle cells. |
| Q37897926 | Calcium and vitamin D for obesity: a review of randomized controlled trials |
| Q35615225 | Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults |
| Q51300676 | Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. |
| Q34493377 | Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review. |
| Q35082702 | Characteristics of glucose metabolism in Nordic and South Asian subjects with type 2 diabetes |
| Q41004601 | Cholecalciferol improves glycemic control in type 2 diabetic patients: a 6-month prospective interventional study |
| Q35898193 | Circulating 25-hydroxyvitamin D concentrations are correlated with cardiometabolic risk among American black and white adolescents living in a year-round sunny climate. |
| Q34155415 | Circulating 25-hydroxyvitamin D is associated with insulin resistance cross-sectionally but not longitudinally in older adults: The Cardiovascular Health Study |
| Q24561964 | Classical and emerging roles of vitamin D in hepatitis C virus infection |
| Q40297111 | Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. |
| Q22306201 | Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis |
| Q26824192 | Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes |
| Q87930125 | Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome |
| Q36189337 | Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis |
| Q92759574 | Correlation of clinical, radiological and serum analysis of hypovitaminosis D with polycystic ovary syndrome: A systematic review and meta-analysis |
| Q35244994 | Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research |
| Q57175868 | Dietary and physical activity recommendations to prevent type 2 diabetes in South Asian adults: A systematic review |
| Q34263443 | Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality |
| Q57712219 | Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial |
| Q35169791 | Does vitamin D play a significant role in type 2 diabetes? |
| Q26851499 | Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? |
| Q91711151 | Effect of High-dose Vitamin D Supplementation on Beta Cell Function in Obese Asian-Indian Children and Adolescents: A Randomized, Double Blind, Active Controlled Study |
| Q34648367 | Effect of Vitamin D Supplementation on C-reactive Protein in Patients with Nonalcoholic Fatty Liver |
| Q35114775 | Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial |
| Q53704701 | Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial. |
| Q58132783 | Effect of Vitamin D Treatment on Glucose Homeostasis and Metabolism in Lebanese Older Adults: A Randomized Controlled Trial |
| Q35197973 | Effect of Vitamin D supplementation on glycemic parameters and progression of prediabetes to diabetes: A 1-year, open-label randomized study |
| Q42510845 | Effect of activated vitamin D on glucoparameters in HCV seropositive and seronegative patients on chronic hemodialysis |
| Q33882011 | Effect of supplementation with vitamin D₃ on glucose production pathways in human subjects |
| Q34733598 | Effect of therapeutic dose of vitamin d on serum adiponectin and glycemia in vitamin d-insufficient or deficient type 2 diabetic patients |
| Q53817805 | Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: A meta-analysis. |
| Q45250739 | Effect of vitamin D on insulin sensitivity in elderly patients with impaired fasting glucose |
| Q51285757 | Effect of vitamin D on stress-induced hyperglycaemia and insulin resistance in critically ill patients. |
| Q35956421 | Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials |
| Q34414603 | Effect of vitamin D supplementation on cardiometabolic risks and health-related quality of life among urban premenopausal women in a tropical country--a randomized controlled trial |
| Q34225331 | Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. |
| Q35755979 | Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis |
| Q33390806 | Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial |
| Q33813679 | Effect of vitamin D supplementation on the level of circulating high-sensitivity C-reactive protein: a meta-analysis of randomized controlled trials |
| Q35627558 | Effect of vitamin D, calcium and multiple micronutrients supplementation on lipid profile in pre-menopausal Bangladeshi garment factory workers with hypovitaminosis D. |
| Q51274280 | Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. |
| Q92641863 | Effects of Vitamin D Supplementation on Body Composition and Metabolic Risk Factors in Men: A Randomized Controlled Trial |
| Q35764892 | Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months. |
| Q51367105 | Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. |
| Q34316048 | Effects of combined calcium and vitamin D supplementation on insulin secretion, insulin sensitivity and β-cell function in multi-ethnic vitamin D-deficient adults at risk for type 2 diabetes: a pilot randomized, placebo-controlled trial |
| Q45729277 | Effects of correction of vitamin D insufficiency on serum osteocalcin and glucose metabolism in obese children |
| Q35125338 | Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial |
| Q38164434 | Effects of vitamin D in skeletal muscle: falls, strength, athletic performance and insulin sensitivity |
| Q47976698 | Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency |
| Q44607362 | Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes |
| Q93260076 | Effects of vitamin D supplementation on androgens in men with low testosterone levels: a randomized controlled trial |
| Q89723997 | Effects of vitamin D supplementation on cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis of randomized controlled trials |
| Q43752728 | Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial |
| Q48215285 | Effects of vitamin D supplementation on inflammatory markers in heart failure: a systematic review and meta-analysis of randomized controlled trials. |
| Q36936855 | Effects of vitamin D supplementation on metabolic indices and hs-CRP levels in gestational diabetes mellitus patients: a randomized, double-blinded, placebo-controlled clinical trial |
| Q44181986 | Effects of vitamin D(2) supplementation on insulin sensitivity and metabolic parameters in metabolic syndrome patients |
| Q89538003 | Elevated Levels of 1,25-Dihydroxyvitamin D in Plasma as a Missing Risk Factor for Celiac Disease |
| Q34465429 | Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities |
| Q56088999 | Exploring the Role of Vitamin D. Comments on Fleury et al. Sun Exposure and Its Effects on Human Health: Mechanisms through Which Sun Exposure Could Reduce the Risk of Developing Obesity and Cardiometabolic Dysfunction. Int. J. Environ. Res. Public H |
| Q93108459 | Extra-Skeletal Effects of Vitamin D |
| Q36746400 | FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle |
| Q57948040 | Fertility Awareness-Based Methods for Family Planning and as an Alternative to Hormonal Contraceptives for Therapeutic Reasons |
| Q35749555 | Focus on vitamin D, inflammation and type 2 diabetes |
| Q46302884 | Genetic variation in the vitamin D receptor, plasma 25-hydroxyvitamin D, and biomarkers of cardiometabolic disease in Caucasian young adults |
| Q35708527 | Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study |
| Q36626604 | High Prevalence of Vitamin D Deficiency and Adverse Pregnancy Outcomes in Yazd, a Central Province of Iran |
| Q45065424 | Higher Dietary Intake of Vitamin D May Influence Total Cholesterol and Carbohydrate Profile Independent of Body Composition in Men with Chronic Spinal Cord Injury. |
| Q38007887 | Hyperinsulinemia, insulin resistance, vitamin D, and colorectal cancer among whites and African Americans |
| Q98946785 | Hypovitaminosis D Is Associated with Some Metabolic Indices in Gestational Diabetes Mellitus |
| Q35658388 | Impact of Vitamin D Replacement on Markers of Glucose Metabolism and Cardio-Metabolic Risk in Women with Former Gestational Diabetes--A Double-Blind, Randomized Controlled Trial |
| Q36802341 | Impact of activated vitamin D on insulin resistance in nondiabetic chronic kidney disease patients |
| Q35193436 | Impact of vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults |
| Q93565659 | In reply |
| Q45107837 | Increasing numbers of citations and higher impact factor in 2012: the British Journal of Nutrition continues to show steady improvement |
| Q51354925 | Incremental cholecalciferol supplementation up to 15 μg/d throughout winter at 51-55° N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. |
| Q35749489 | Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients |
| Q35891498 | Insulin secretion and sensitivity in healthy adults with low vitamin D are not affected by high-dose ergocalciferol administration: a randomized controlled trial |
| Q43892885 | Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects |
| Q59329358 | Inverse Relationship between Metabolic Syndrome and 25-Hydroxyvitamin D Concentration in Elderly People without Vitamin D deficiency |
| Q51269949 | Investigation of vitamin D status and its correlation with insulin resistance in a Chinese population. |
| Q36187648 | Is vitamin D status relevant to metabolic syndrome? |
| Q36249627 | Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. |
| Q51371709 | Low serum vitamin D is associated with high risk of diabetes in Korean adults. |
| Q30235602 | Low vitamin D status and obesity: Role of nutritionist |
| Q35018209 | Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults |
| Q38167662 | Maternal and in utero determinants of type 2 diabetes risk in the young |
| Q36124233 | Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study |
| Q37990069 | Mechanistic roles for calcium and vitamin D in the regulation of body weight |
| Q28068999 | Meta-Analysis of Milk Consumption and the Risk of Cognitive Disorders |
| Q26799612 | Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome |
| Q90155361 | No effect of vitamin D supplementation on metabolic parameters but on lipids in patients with type 2 diabetes and chronic kidney disease |
| Q43901101 | Non-linear association between 25-hydroxyvitamin D and the incidence of type 2 diabetes: a community-based nested case-control study. |
| Q47373449 | Noncalcemic adverse effects and withdrawals in randomized controlled trials of long-term vitamin D2 or D3 supplementation: a systematic review and meta-analysis. |
| Q35670937 | Nonclassical vitamin D action |
| Q95360575 | Nonfat milk attenuates acute hyperglycemia in individuals with android obesity: A randomized control trial |
| Q38186619 | Nutrients other than carbohydrates: their effects on glucose homeostasis in humans |
| Q58782777 | Nutritional issues in patients with obesity and cirrhosis |
| Q36401313 | Optimal Vitamin D Supplementation Doses that Minimize the Risk for Both Low and High Serum 25-Hydroxyvitamin D Concentrations in the General Population |
| Q64126927 | Oral vitamin D supplementation has a lower bioavailability and reduces hypersecretion of parathyroid hormone and insulin resistance in obese Chinese males |
| Q90657803 | PREVALENCE OF VITAMIN D DEFICIENCY IN URBAN SOUTH INDIANS WITH DIFFERENT GRADES OF GLUCOSE TOLERANCE |
| Q33768201 | Patterns, control and complications of diabetes from a hospital based registry established in a low income country |
| Q37373923 | Plasma 25-Hydroxyvitamin D Is Related to Protein Signaling Involved in Glucose Homeostasis in a Tissue-Specific Manner |
| Q51186034 | Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and cardiometabolic disease risk in an ethnically diverse population of young adults. |
| Q36521130 | Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study |
| Q41833295 | Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients |
| Q37230115 | Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study |
| Q35599827 | Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia |
| Q35981722 | Prevalence of Vitamin D Insufficiency and Deficiency among Young Physicians at University District Hospital in San Juan, Puerto Rico |
| Q38244532 | Prevalence of vitamin d insufficiency in qatar: a systematic review |
| Q35405441 | Prospective associations of vitamin D with β-cell function and glycemia: the PROspective Metabolism and ISlet cell Evaluation (PROMISE) cohort study |
| Q33620889 | Randomized controlled trials of vitamin D and cancer incidence: A modeling study |
| Q34437639 | Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial |
| Q92755303 | Re: Scragg-Emerging Evidence of Thresholds for Beneficial Effects from Vitamin D Supplementation |
| Q84924820 | Record citations in 2011 contribute to maintenance of the impact factor of BJN |
| Q37492620 | Relation between dairy food intake and cognitive function: The Maine-Syracuse Longitudinal Study |
| Q41508209 | Relationship between serum vitamin D levels and angiographic severity and extent of coronary artery disease |
| Q33590784 | Relationship of vitamin D, HIV, HIV treatment, and lipid levels in the Women's Interagency HIV Study of HIV-infected and uninfected women in the United States |
| Q37829546 | Requirements for Vitamin D across the life span |
| Q36138452 | Response to an adequate dietary intake of vitamin D3 modulates the effect of estrogen therapy on bone density |
| Q28538127 | Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users |
| Q36229014 | Role of vitamin D in insulin resistance |
| Q38069543 | Role of vitamin D in the development of insulin resistance and type 2 diabetes |
| Q36825786 | Role of vitamin d in cardiometabolic diseases |
| Q90253714 | Safety and tolerability of 6-month supplementation with a vitamin D, calcium and leucine-enriched whey protein medical nutrition drink in sarcopenic older adults |
| Q37348593 | Serum 25-Hydroxyvitamin D Concentration Is Independently Inversely Associated with Insulin Resistance in the Healthy, Non-Obese Korean Population. |
| Q51349934 | Serum 25-hydroxyvitamin D and markers of insulin resistance in a Japanese working population. |
| Q40765871 | Serum 25-hydroxyvitamin D concentrations and cardiometabolic risk factors in adolescents and young adults |
| Q92235643 | Serum 25-hydroxyvitamin D is associated with obesity and metabolic parameters in US children |
| Q35043732 | Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study) |
| Q37842680 | Shining D' light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D. |
| Q35713388 | Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veterans. |
| Q33783225 | Special considerations for vitamin D in the south Asian population in the UK. |
| Q33936917 | Study protocol: a randomised placebo-controlled clinical trial to study the effect of vitamin D supplementation on glycaemic control in type 2 Diabetes Mellitus SUNNY trial |
| Q34696523 | Study protocol: the effect of vitamin D supplements on cardiometabolic risk factors among urban premenopausal women in a tropical country -- a randomized controlled trial |
| Q34402156 | Sunlight and Vitamin D: A global perspective for health |
| Q34664230 | Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromsø. |
| Q34572659 | Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity |
| Q22305327 | Systematic Review: Vitamin D and Cardiometabolic Outcomes |
| Q46093623 | Systems biology of personalized nutrition |
| Q31146669 | The Association of vitamin D status and fasting glucose according to body fat mass in young healthy Thais |
| Q41601458 | The Effects of Aerobic Exercises and 25(OH) D Supplementation on GLP1 and DPP4 Level in Type II Diabetic Patients |
| Q37281005 | The Impact of Vitamin D Supplementation on Post-Partum Glucose Tolerance and Insulin Resistance in Gestational Diabetes: A Randomized Controlled Trial |
| Q35816106 | The Relationship of Serum 25-Hydroxyvitamin D and Insulin Resistance among Nondiabetic Canadians: A Longitudinal Analysis of Participants of a Preventive Health Program. |
| Q39658708 | The associations of vitamin D status and dietary calcium with the metabolic syndrome: an analysis of the Victorian Health Monitor survey |
| Q46205837 | The effect of different doses of vitamin D supplementation on insulin resistance during pregnancy |
| Q42993191 | The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial |
| Q34184615 | The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes |
| Q51070097 | The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland. |
| Q36651578 | The effect of vitamin D on insulin resistance in patients with type 2 diabetes |
| Q35834308 | The effect of vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: systematic review with meta-analysis. |
| Q30252056 | The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis |
| Q90178411 | The effect of vitamin D supplementation on the glycemic control of pre-diabetic Qatari patients in a randomized control trial |
| Q37034916 | The effects of oral vitamin D on insulin resistance in pre-diabetic patients |
| Q33740329 | The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus |
| Q35024681 | The effects of vitamin D₂ or D₃ supplementation on glycaemic control and related metabolic parameters in people at risk of type 2 diabetes: protocol of a randomised double-blind placebo-controlled trial |
| Q35114785 | The effects of vitamin d on insulin release from isolated islets of rats |
| Q37527022 | The impact of Vitamin D Replacement on Glucose Metabolism |
| Q38685735 | The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials |
| Q40778501 | The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and β-cell function |
| Q34743179 | The influence of early exposure to vitamin D for development of diseases later in life |
| Q35855739 | The malnutrition of obesity: micronutrient deficiencies that promote diabetes |
| Q36003426 | The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. |
| Q36409061 | The problems of vitamin d insufficiency in older people |
| Q35109649 | The relationship between serum 25-hydroxy vitamin D and insulin sensitivity and β-cell function in newly diagnosed type 2 diabetes. |
| Q35791100 | The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes |
| Q36783562 | The role of vitamin D in the metabolic homeostasis of diabetic bone |
| Q38795686 | The role of vitamin D in the prevention of type 2 diabetes. To D or not to D? |
| Q36953793 | Therapeutic effects of 1,25-dihydroxyvitamin D3 on diabetes-induced liver complications in a rat model |
| Q38586642 | Tie-2Cre mediated deletion of the vitamin D receptor gene leads to improved skeletal muscle insulin sensitivity and glucose tolerance |
| Q37704860 | Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation |
| Q37869188 | Update on vitamin D and type 2 diabetes |
| Q26824885 | Vitamin D & endothelial function |
| Q90616812 | Vitamin D Deficiency at Mid-Pregnancy Is Associated with a Higher Risk of Postpartum Glucose Intolerance in Women with Gestational Diabetes Mellitus |
| Q92987459 | Vitamin D Deficiency: Consequence or Cause of Obesity? |
| Q41422850 | Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients. |
| Q37060645 | Vitamin D Status Is Negatively Correlated with Insulin Resistance in Chinese Type 2 Diabetes. |
| Q64084673 | Vitamin D Status, Calcium Intake and Risk of Developing Type 2 Diabetes: An Unresolved Issue |
| Q48069746 | Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial |
| Q41182983 | Vitamin D Supplementation Enhances C18(dihydro)ceramide Levels in Type 2 Diabetes Patients |
| Q92643535 | Vitamin D Supplementation in Overweight/obese Asian Indian Women with Prediabetes Reduces Glycemic Measures and Truncal Subcutaneous Fat: A 78 Weeks Randomized Placebo-Controlled Trial (PREVENT-WIN Trial) |
| Q55380386 | Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis. |
| Q90543480 | Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis |
| Q26766181 | Vitamin D and Diabetic Complications: True or False Prophet? |
| Q37813833 | Vitamin D and cardiometabolic health: a review of the evidence |
| Q38041958 | Vitamin D and cardiovascular disease: is there evidence to support the bandwagon? |
| Q37997996 | Vitamin D and cardiovascular risk |
| Q33976563 | Vitamin D and diabetes |
| Q87383723 | Vitamin D and diabetes |
| Q38773655 | Vitamin D and diabetes mellitus: Causal or casual association? |
| Q38163816 | Vitamin D and energy homeostasis: of mice and men. |
| Q37762187 | Vitamin D and health status in elderly |
| Q59925852 | Vitamin D and inflammation |
| Q38366390 | Vitamin D and insulin resistance |
| Q28066198 | Vitamin D and its effects on cardiovascular diseases: a comprehensive review |
| Q84464931 | Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect? |
| Q57385057 | Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood |
| Q38361922 | Vitamin D and risk of CVD: a review of the evidence |
| Q38072776 | Vitamin D and type 2 diabetes mellitus (D2). |
| Q33789504 | Vitamin D and type 2 diabetes: a systematic review |
| Q38197191 | Vitamin D deficiency & childhood obesity: a tale of two epidemics. |
| Q34728285 | Vitamin D deficiency in chronic liver disease. |
| Q26864727 | Vitamin D deficiency: a new risk factor for type 2 diabetes? |
| Q30403062 | Vitamin D deficiency: implications for acute care in the elderly and in patients with chronic illness. |
| Q39540648 | Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: a randomized controlled trial |
| Q59299771 | Vitamin D in Obesity and Weight Loss |
| Q92605722 | Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy |
| Q37776370 | Vitamin D nutritional policy needs a vision for the future |
| Q42514140 | Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. |
| Q33579559 | Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana |
| Q33757938 | Vitamin D status is inversely associated with markers of risk for type 2 diabetes: A population based study in Victoria, Australia |
| Q40344743 | Vitamin D status is not related to insulin resistance in different phenotypes of moderate obesity |
| Q36951115 | Vitamin D status: a review with implications for the pelvic floor |
| Q34404297 | Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials |
| Q36157902 | Vitamin D supplementation during exercise training does not alter inflammatory biomarkers in overweight and obese subjects |
| Q24201160 | Vitamin D supplementation for prevention of mortality in adults |
| Q35923664 | Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial |
| Q24186477 | Vitamin D supplementation for women during pregnancy |
| Q24203647 | Vitamin D supplementation for women during pregnancy |
| Q40640138 | Vitamin D testing patterns among general practitioners in a major Victorian primary health care service. |
| Q35596938 | Vitamin D versus placebo in improvement of endothelial dysfunction: a meta-analysis of randomized clinical trials. |
| Q26991851 | Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies |
| Q35405187 | Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique |
| Q39242378 | Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. |
| Q37700591 | Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial |
| Q50077024 | Vitamin D3-fortified milk did not affect glycemic control, lipid profile, and anthropometric measures in patients with type 2 diabetes, a triple-blind randomized clinical trial |
| Q37538266 | Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare |
| Q37801923 | Vitamin D: a hormone for all seasons. |
| Q37897925 | Vitamin D: the light side of sunshine |
| Q50937532 | Vitamin d and cardiovascular disease. |
| Q34605273 | Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. |
| Q27022122 | Vitamins and type 2 diabetes mellitus |
| Q54574587 | [Vitamin D : More than just a bone hormone]. |
Search more.